Flurbiprofen Sodium + HPMCThird Party Manufacturing in India

Flurbiprofen Sodium + HPMC works by combining a cyclooxygenase inhibitor with a viscoelastic structural polymer. It inhibits prostaglandin biosynthesis to prevent intraoperative miosis and post-surgical swelling, while the high molecular weight polymer increases corneal contact time and protects corneal epithelial tissue. Unlike traditional water-based drops, it forms a cohesive protective layer over the ocular matrix to delay active ingredient drainage. It is highly effective and well-tolerated during extensive ophthalmic procedures.

Therapeutic Uses

• Intraoperative Miosis Prevention: Inhibition of pupillary constriction during active surgical lens replacement.
• Postoperative Inflammation Management: Prolonged control of pain and physical swelling following anterior segment ophthalmic surgery.
• Ocular Surface Protection: Lubrication of irritated corneal tissue during recovery from specialized ocular interventions.

Why Manufacturers Choose Flurbiprofen Sodium + HPMC

Flurbiprofen Sodium + HPMC third party manufacturing in India is highly attractive because of its specialized clinical use in modern cataract care centers. Our partner manufacturing lines feature automated viscosity-handling technology within strict WHO-GMP regulated spaces to achieve consistent dispersion and bubble-free filling. Utilizing these WHO-GMP certified systems ensures the high level of sterile purity required for direct surgical applications. This advanced configuration elevates product profiles, enabling higher market positioning compared to basic lubricating drops.